Recombinant Proteins & Enzymes
•27 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (27)
| Company | Market Cap | Price |
|---|---|---|
|
TMO
Thermo Fisher Scientific Inc.
Thermo Fisher sells recombinant proteins & enzymes used in biotech research and production workflows.
|
$210.50B |
$558.35
+0.13%
|
|
ZTS
Zoetis Inc.
Monoclonal antibodies are recombinant proteins, aligning with Recombinant Proteins & Enzymes.
|
$64.74B |
$144.25
-0.80%
|
|
IFF
International Flavors & Fragrances Inc.
DEB and enzyme-based biotechnologies are core to IFF's Health & Biosciences innovation and product offerings.
|
$16.60B |
$63.57
-2.02%
|
|
TECH
Bio-Techne Corporation
Bio-Techne's core business includes recombinant proteins and enzymes used as highly characterized reagents across life-science workflows.
|
$10.02B |
$61.70
-3.50%
|
|
DNLI
Denali Therapeutics Inc.
DNL310 and DNL126 are recombinant enzymes delivered via Denali's TransportVehicle platform, representing its core product categories.
|
$2.46B |
$16.38
-3.19%
|
|
TWST
Twist Bioscience Corporation
Twist develops proprietary enzymes (e.g., high-fidelity polymerase and ligase) which fall under Recombinant Proteins & Enzymes.
|
$2.01B |
$32.37
-3.57%
|
|
KOD
Kodiak Sciences Inc.
Antibodies are recombinant proteins, aligning with Recombinant Proteins & Enzymes.
|
$1.02B |
$19.00
-1.25%
|
|
INBX
Inhibrx Biosciences, Inc.
Recombinant proteins/biologics production via engineered platforms.
|
$991.45M |
$72.41
+5.72%
|
|
MRVI
Maravai LifeSciences Holdings, Inc.
Enzymes and recombinant proteins (e.g., CleanScribe RNA Polymerase) are core inputs, aligning with MRVI's NAP BST tech stack and manufacturing capabilities.
|
$822.55M |
$3.10
-3.87%
|
|
SVRA
Savara Inc.
Molgramostim is a recombinant GM-CSF protein delivered as an inhalation therapy; directly a recombinant protein/enzymes product.
|
$762.21M |
$4.33
-1.70%
|
|
NKTR
Nektar Therapeutics
Rezpegaldesleukin is a recombinant protein therapeutic (PEGylated IL-2), matching Recombinant Proteins & Enzymes.
|
$755.83M |
$59.73
-1.95%
|
|
TECX
Tectonic Therapeutic, Inc.
TX45 is a recombinant fusion protein (Fc-relaxin) developed using TECX's GEODe platform, fitting the Recombinant Proteins & Enzymes category.
|
$333.86M |
$18.58
+3.91%
|
|
IMMP
Immutep Limited
eftilagimod alfa is a recombinant LAG-3Ig fusion protein, fitting Recombinant Proteins & Enzymes.
|
$289.66M |
$2.00
+0.75%
|
|
LRMR
Larimar Therapeutics, Inc.
Nomlabofusp is a recombinant fusion protein, i.e., a recombinant protein/enzyme therapeutic.
|
$278.52M |
$4.32
-0.80%
|
|
MDWD
MediWound Ltd.
MediWound's core products are enzymatic proteins/enzymes (NexoBrid, EscharEx) used for wound debridement, aligning with Recombinant Proteins & Enzymes.
|
$192.04M |
$18.05
-1.18%
|
|
PLX
Protalix BioTherapeutics, Inc.
Protalix manufactures recombinant proteins/enzymes (e.g., Elelyso, Elfabrio) using its plant-based ProCellEx system.
|
$183.10M |
$2.37
+2.83%
|
|
MOLN
Molecular Partners AG
DARPins are recombinant proteins; the company manufactures these protein therapeutics.
|
$124.48M |
N/A
|
|
KBLB
Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories produces recombinant spider silk proteins via transgenic silkworms, a core product category defined as Recombinant Proteins & Enzymes.
|
$96.23M |
$0.09
|
|
STTK
Shattuck Labs, Inc.
Work with recombinant antibodies/proteins aligns with Recombinant Proteins & Enzymes as a core product category.
|
$95.80M |
$1.95
-2.75%
|
|
JANL
Janel Corporation
Life Sciences activities include recombinant proteins and enzymes production (antibodies, reagents).
|
$42.72M |
$36.01
|
|
XLO
Xilio Therapeutics, Inc.
Recombinant Proteins & Enzymes applies to Xilio's recombinant therapeutic biologics (antibodies and IL-12).
|
$42.46M |
$0.81
-1.65%
|
|
MURA
Mural Oncology plc
Lead and preclinical assets are recombinant cytokine proteins (e.g., nemvaleukin alfa; IL-18/IL-12 programs), fitting Recombinant Proteins & Enzymes.
|
$36.09M |
$2.10
+0.24%
|
|
DYAI
Dyadic International, Inc.
Company directly produces recombinant proteins and enzymes (e.g., RHSA, transferrin, DNase1, RNase inhibitors, FGF, lactalbumin, lactoferrin) for life sciences, diagnostics, and food/industrial uses.
|
$34.00M |
$1.14
+0.88%
|
|
RNTX
Rein Therapeutics Inc.
LTI-1.00 is a protein-based proenzyme therapy, aligning with Recombinant Proteins & Enzymes.
|
$29.24M |
$1.55
+17.80%
|
|
CLGN
CollPlant Biotechnologies Ltd.
rhCollagen is a recombinant protein, and CollPlant's core product is plant-derived recombinant human collagen used in implants, fillers, and bioinks.
|
$26.46M |
$2.24
-3.03%
|
|
PPCB
Propanc Biopharma, Inc.
PRP is a proenzyme-based therapy, aligning with recombinant proteins & enzymes as a direct product category.
|
$16.49M |
$1.26
-10.92%
|
|
ENTO
Entero Therapeutics, Inc.
Adrulipase is a recombinant lipase enzyme produced as a therapeutic for exocrine pancreatic insufficiency, fitting Recombinant Proteins & Enzymes.
|
$6.27M |
$4.28
+8.35%
|
Loading industry trends...
Loading research report...
